isoprinosine tab 500mg tablet
systemed inc. - inosine pranobex - tablet - 500mg - inosine pranobex 500mg - antivirals
isoprinosine tablet
newport pharmaceuticals limited - inosine pranobex - tablet - 500mg - inosine pranobex 500mg - antivirals
isoprinosine tab. 400mg (イソプリノシン錠400mg)
mochida pharmaceutical co., ltd. - inosine pranobex - white tablet, diameter: 12.0 mm, thickness: 3.5 mm
imunovir tablet
kora healthcare - inosine pranobex - tablet - 500mg - inosine pranobex 500mg - miscellaneous antivirals
epinosine b forte injection
wael pharmacy - disodium adenosine triphosphate trihydrate, nicotinamide - injection
imunovir
new zealand medical & scientific ltd - inosine pranobex 500mg - tablet - 500 mg - active: inosine pranobex 500mg excipient: magnesium stearate
groprinosin tablets
gedeon richter polska sp. z o.o. 5 - inosine pranobex - tablets - 500mg
rejuvesol- sodium pyruvate, inosine, adenine, sodium phosphate, dibasic, and sodium phosphate, monobasic, monohydrate solution
citra labs, llc - sodium pyruvate (unii: pod38aif08) (pyruvic acid - unii:8558g7rutr), inosine (unii: 5a614l51ct) (inosine - unii:5a614l51ct), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium pyruvate 0.55 g in 50 ml - rejuvesol ® solution is intended only for the extracorporeal rejuvenation of a rbc. it should never be directly administered to humans. rejuvesol ® solution must not be added to whole blood because the additional plasma may reduce the effectiveness of the rejuvenation process. immediately after rejuvenation, rbc must either be washed via an approved protocol prior to transfusion or glycerolized and frozen. rbc which have been rejuvenated, glycerolized, and frozen must be deglycerolized via an approved protocol prior to transfusion. rbc rejuvenated before 6 days of storage may achieve 2,3-dpg levels in excess of 2 times normal and atp levels in excess of 1.5 times normal. 5,6 in patients with reduced arterial blood p0 2 of less than 40 torr, the use of rbc rejuvenated before 6 days of storage are contraindicated because their high 2,3-dpg levels and low oxygen affinity may impair proper oxygenation of the red blood cells in the lung. 7 rej
immunosin 250 mg/5 ml syrup
unilab, inc. - inosine dimepranol acedoben - syrup - 250 mg/5 ml